Paper
8 January 2024 Etiology, diagnosis and treatments of pulmonary hypertension
Yinuo Chen
Author Affiliations +
Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 1292436 (2024) https://doi.org/10.1117/12.3013013
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom
Abstract
Pulmonary hypertension is a kind of syndrome with complex pathogenesis and multi-factor involvement. The most common initial clinical symptoms are shortness of breath after activity, fatigue, chest pain, and hemoptysis. In some patients, circulatory disturbance or arrhythmia may be accompanied by vertigo, syncope, and palpitation. Most patients usually survive only two to three years from diagnosis to death. This paper summarizes the biological background of the pulmonary artery in recent years, the treatment methods, and the comparison between this method and other methods, so as to make predictions for the future development of pulmonary hypertension treatment, and provide references for existing treatment, and makes recommendations for possible problems.
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Yinuo Chen "Etiology, diagnosis and treatments of pulmonary hypertension", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 1292436 (8 January 2024); https://doi.org/10.1117/12.3013013
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Pulmonary hypertension

Arteries

Pulmonary disorders

Vascular diseases

Cardiovascular disorders

Lung

Heart

Back to Top